Some items on our site have recently moved. Visit our News Hub for selected articles, special reports, podcasts and other resources.
Siemens set for December verdict in South Korean dominance abuse appeal
28 October 2019 00:00
German conglomerate Siemens’ appeal against an antitrust case decision by South Korea's competition regulator will produce a verdict before the end of the year, MLex has learned.
It is understood that the Seoul High Court has tentatively set Dec. 12 as the date for an announcement of its decision in the legal battle between Siemens' local affiliates and the Korea Fair Trade Commission.
Siemens, Siemens Healthcare and Siemens Healthineers were last year fined a combined 6.2 billion won ($5.3 million) by the KFTC and handed corrective orders for abusing their dominance in the South Korean aftermarket for computed tomography and magnetic resonance imaging scanners. It was the first case in which the KFTC sanctioned a company for dominance abuses in an aftermarket.
The regulator found that the companies had abused their dominant position in the markets for CT and MRI scanners, which are key pieces of medical equipment used widely in hospitals — markets in which, according to the regulator, they had the largest share for four consecutive years, from 2012 to 2015.
Siemens, Siemens Healthcare and Siemens Healthineers expressed their intent to challenge the decision immediately because medical equipment maintenance services are considered intellectual property rights, and South Korean law guarantees the right of IP owners to receive licensing fees. They filed their appeal in April 2018, leading to litigation that lasted for more than a year.
03 October 2022 00:00 by Claude MarxThe House passed a bill that combined three measures which advocates of stronger enforcement
26 September 2022 16:15 by Simon ZekariaDigital economy presents new scenarios for competition policy for which regulators and courts need "novel" and "creative" approaches
23 September 2022 10:34 by Simon ZekariaUK collective action regime that pursues damages for businesses and consumers over alleged competition-law infringements